Imatinib in Patients With Desmoid Tumor and Chondrosarcoma
NCT00928525
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
35
Enrollment
NETWORK
Sponsor class
Conditions
Advanced Desmoid Tumor
Advanced Chondrosarcoma
Interventions
DRUG:
Imatinib Mesylate
Sponsor
Italian Sarcoma Group